What is Behavidence?
Founded in 2020, Behavidence specializes in developing advanced machine learning-based tools designed for the remote monitoring and management of mental health conditions. Leveraging passive digital biomarkers, the company's solutions aim to improve the lives of individuals affected by psychiatric and neurological disorders. Behavidence offers multiple digital phenotyping models capable of predicting conditions such as depression, anxiety, and ADHD. These disruptive solutions have been adopted by various health organizations, technology firms, commercial entities, and government agencies, providing real-time feedback with user privacy and zero respondent burden.
How much funding has Behavidence raised?
Behavidence has raised a total of $4.3M across 1 funding round:
Angel/Seed
$4.3M
Angel/Seed (2022): $4.3M with participation from Welltech Ventures, Longevity Venture Partners, and Arc Impact
Key Investors in Behavidence
Welltech Ventures
Welltech Ventures is a venture capital fund focused on wellness technology, investing in startups that enhance health and longevity through personalized medicine and mental health solutions.
Longevity Venture Partners
Longevity Venture Partners is an early-stage investment firm concentrating on Silvertech, Healthcare, and Wellness sectors, aiming to foster global growth for its portfolio companies.
Arc Impact
Arc Impact invests in early-stage startups across education, workforce training, and healthcare, with a focus on enhancing technology accessibility and improving health outcomes.
What's next for Behavidence?
The substantial enterprise-level funding positions Behavidence for accelerated growth and market expansion. With a focus on scaling its digital phenotyping solutions, the company is poised to further penetrate the health tech and AI sectors. Future strategic investments will likely support the enhancement of its predictive models and the broadening of its adoption across clinical interventions, employee wellness programs, and governmental health initiatives. The company's trajectory suggests a move towards solidifying its role as a leader in data-driven mental health assessment and management.
See full Behavidence company page
